Winner Medical Co. Ltd. Class A · SZSE:300888
Winner Medical Co. Ltd. Class A — Investor Presentation (February 2009)
16 slides from Winner Medical Co. Ltd. Class A's investor presentation, Feb 18, 2009
Slide 1: Winner Medical: A Leading Medical Dressings Manufacturer and Distributor
Weimer WINNER MEDICAL A Leading Medical Dressings Manufacturer and Distributor ruary 2009 Secunties Exchange, A 3s amended of historieal fact inched ‘herein ‘are. “Yorward 0 ements, regarding Winn oup Ine. and Strategy, plans and. objec mens of non-hist iboling statements are ofan identified by the
Slide 2: Company Overview
Company Overview Jing company engaged in the manufacture, research and marketing of medical Leading Manufacturer of Medical Dressing (Medical and Wound Care) Products from China 4 Business Lines: Medical Gare, Wound Cave, Heme Gare and PurGotton Products Robust Reverue Growth ‘Company Facts: Stock I
Slide 3: Executing a Focused Strategy to Drive Growth and Profitability
Executing a Focused Strategy to Drive Growth and Profitability + Consolidate Product Portfolio & Customer Mix to Drive Margin Growth — Migrating to higher margin products and reducing production and sales of non-core and low growth products = Focus on expansion and penetration into leading internati
Slide 4: Growth in Exports from China
Growth in Exports from China Strengthening Overseas Market ‘Medical Dressing Exports from China Penetration + Export growth is diven by manufacturing shift to lower-cost labor and manufacturing ust * China exported $708 milion worth of e120 medical dressing (medical and wound care) products in 2007"
Slide 5: Product lines: medical care, wound care, home care and PurCotton
» produits - perating room products, procedural packs, protective products an und care products - dressing pads, cotton products, retention products and dental products cdketchiefe sweat pade, bby woar and bathing & = PurCotton products and surgical gow ls for consumer raw materials, operating room
Slide 6: Medical Care Products
Medical Care Products Wound Care Products Womer winneR meoicaL
Slide 7: Market Opportunity for PurCotton
Wemer winner meoicaL Market Opp for PurCotton, a Substitute for Woven Cotton and Non- Woven Synthetic Fabric + Nonwoven market potential 3s of nonwoven products a the preducer level nthe Novth Amica amounted to $4 87 billon in 1. The induaty Is forecasted by INDA to grow by mare Duan 4% & year ove t
Slide 8: Revenue Expansion Opportunities - Innovative Product Development - PurCotton
Revenue Expansion Opportunities — Innovative Product Development — PurCotton PurCotton ton nonwoven praducts tented manufacturing methodology for the 100% ind 34 Member states cuntries and regions '= Obtained patent in China, the U.S., Russia, ofthe European Patent Office, patent appl ‘= New technol
Slide 9: Diversified customer base and R&D efforts
road * 18+ years of business relationships with leading m and distributors that employ high quality standards itinational medical producers * Diversified customer bas ximately 45% of fiscal 20 of 150+ client , with the top 10 customers ac annual revenue ounting Cardinaleain vernohearus United States
Slide 10: Vertically Integrated and Expanding Production Capacities
Vertically Integrated and Expanding Production Capacities Strict Quality Controls; Advanced Production Technology Fully in Upstream raw material processing ta export of arated production capabilties rom finished products ‘Provides total procurement solutions to customers, including design and R&D su
Slide 11: Q1 FY09 Financial Results
revenue 25,730 19.828 499.14 Goss Proft 6,603 4,900 Other Operating Income 495 +52.08 Exchange Difference, not 28s Operating exxenses 4450 42441 Income fer op 1748 8073 let incorre 1475 4,462 426.94 Wemer winner meoicaL jon, a 33.14% Y-0-¥ Increase % Y-0-¥ Ink + Q1FY09 Gross Margin: 25.66% (Gross Pr
Slide 12: Revenue by Market
Revere by Market so) a2 aa 40 .% 17193 iad 2 101 88 ns 18 10 ‘i of =I nw tos atos mEsrope Japan Americas «Chinas Other ros x08 Revenue by Market Revenue by Market Wimer winner meorcaL ash and cash equivalents 773 6.46 Accounts Re 1289 1982 vento 1138 154 Total Assats 101.68 10192 Short term bank loa
Slide 13: Investment Highlights
Investment Highlights Solid Revenue Growth with a Strong Focus on Profitability — Consistent robust revenue grovth: CAGR 21.01% 2003-2008 = Focus on margin growth to enhance proftabilty + Extensive Overseas Distribution Network and Strong Market Leadership Posttion ~ Largest exporter by volume In Ch
Slide 14: Organizational Structure
Wemer WINNER MEDICAL Organizational Structure Wormer winner meoicac.
Slide 15: Major Products with FDA Approval
Major Products with FDA Approval Grmer winner menicat, Weimer winner meoicaL
Slide 16: Facilities
_ilities Eight factories in Hubei Province, Shenzhen and Huanggang + All facilties in China occupy nearly 889 thousand sq. meters, = Hubs factoy = Shenzhen factory * A workforce of more than 4,000 * Upstream manufacturing faci growing region * ISO 9001-2000, 180 13486: 20 ‘System Regulation otze riv
Winner Medical Group — Investor Presentation (February 2009) on 6ix